Plain-English translation of NCT07052578 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Researchers are trying to better understand how to treat men with aggressive, advanced prostate cancer that still responds to hormone therapy. This study will follow about 400 men in Russia to see what treatments doctors are using and will test their blood samples for specific genetic changes that might affect their cancer. The goal is to learn more about treatment patterns and how genetic testing might help guide future care decisions.
Aggressive prostate cancer can spread quickly, and doctors need better information about which treatments work best and how genetic testing of cancer cells might help personalize treatment. This study will collect real-world information about how doctors are currently treating this disease and whether genetic testing can help predict outcomes.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic twice over about 12 months. At your first visit, researchers would review your medical records and collect information about your cancer diagnosis and treatments you have received. You would also donate a blood sample for genetic testing at this visit. At your second visit (around 12 months later, or sooner if your cancer progresses), researchers would check on your health and collect information about any new treatments or changes in your condition. All visits follow your normal medical care routine—no extra procedures beyond what you'd normally receive.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Russia